Pharmaceuticals

Chorionic Gonadotropin Market Growth Patterns And Forecast Outlook Through 2030

May 5, 2026May 5, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Anticipated Rise In Market Value Of The Chorionic Gonadotropin Market During The Forecast Period?

The chorionic gonadotropin market has demonstrated robust expansion over recent years. It is anticipated to increase from $1.34 million in 2025 to $1.43 million in 2026, achieving a compound annual growth rate (CAGR) of 6.5%. The historical growth of this market can be linked to several factors, including the escalation of infertility treatments, its well-established role in stimulating ovulation, an increase in male reproductive disorders, fertility programs based in hospitals, and its extensive clinical history.

The chorionic gonadotropin market is projected to experience robust expansion in the upcoming period. Its valuation is anticipated to reach $1.82 million by 2030, exhibiting a compound annual growth rate (CAGR) of 6.2%. This growth during the projection period stems from factors such as increasing global infertility rates, the proliferation of assisted reproductive technologies, heightened understanding of male hormonal imbalances, a rise in oncology diagnostic uses, and broader accessibility via retail pharmacies. Key trends foreseen over this duration involve the expanding utilization in assisted reproductive interventions, growing deployment in male hypogonadism treatment, a heightened demand for fertility hormone therapies, broader diagnostic application as a tumor marker, and advancements in formulations leading to more precise dosage.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19888&type=smp

What Major Factors Are Driving The Chorionic Gonadotropin Market Forward?

The increasing occurrence of infertility challenges is anticipated to boost the expansion of the chorionic gonadotropin market in the coming years. Infertility is defined as the inability to achieve pregnancy after a year of consistent, unprotected intercourse for individuals under 35, or after six months for those aged 35 and above. The growing incidence of infertility is primarily linked to individuals postponing parenthood and lifestyle elements such as excessive weight and smoking, which detrimentally affect reproductive well-being. Chorionic Gonadotropin (hCG) finds application in fertility procedures, assisting women with ovulation, aiding the luteal phase to sustain pregnancy, and encouraging testosterone generation in men to enhance sperm count, thereby tackling various infertility concerns. For example, in April 2023, the World Health Organization (WHO), a specialized agency located in Switzerland, reported that around 17.5% of adults, equivalent to 1 in 6 people worldwide, face infertility, highlighting the critical demand for accessible, quality fertility care. Consequently, the rising prevalence of infertility issues is fueling the growth of the chorionic gonadotropin market.

Which Segment Classifications Are Used In The Chorionic Gonadotropin Market Segment Analysis?

The chorionic gonadotropin market covered in this report is segmented –

1) By Type: Human Chorionic Gonadotropin, Animal Chorionic Gonadotropin

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By Therapeutic Application: Male Hypogonadism, Female Infertility Treatment, Oligospermic Treatment, Cryptorchidism Treatment, Chronic Pain, Other Therapeutic Applications

4) By End User: Research Institutions, Pharmaceutical Companies

Which Trends Are Impacting The Progress Of The Chorionic Gonadotropin Market?

Major companies within the chorionic gonadotropin market are prioritizing the development of innovative solutions, such as saliva-based pregnancy tests, to boost convenience, accuracy, and accessibility. A saliva-based pregnancy test refers to a non-invasive diagnostic technique that identifies pregnancy by analyzing a woman’s saliva for the presence of human chorionic gonadotropin (hCG), a hormone generated during pregnancy. For instance, in June 2023, Salignostics, an Israel-based biotech company, launched the world’s first saliva-based pregnancy test. This innovative product allows women to determine pregnancy using a saliva sample instead of urine, detecting the hormone hCG (human chorionic gonadotropin) with results available in just 5 to 15 minutes. Salistick provides a more comfortable and convenient testing experience, enabling users to test anywhere and share the moment with partners or loved ones.

Which Firms Are Contributing To The Chorionic Gonadotropin Market Ecosystem?

Major companies operating in the chorionic gonadotropin market are Ferring Pharmaceuticals

Get The Full Chorionic Gonadotropin Market Report:

https://www.thebusinessresearchcompany.com/report/chorionic-gonadotropin-global-market-report

Which Region Dominates The Chorionic Gonadotropin Market By Market Share?

North America was the largest region in the chorionic gonadotropin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chorionic gonadotropin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Chorionic Gonadotropin Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/chorionic-gonadotropin-global-market-report

Browse Through More Reports Similar to the Global Chorionic Gonadotropin Market 2026, By The Business Research Company

Human Chorionic Gonadotropin Market Report 2026

https://www.thebusinessresearchcompany.com/report/human-chorionic-gonadotropin-global-market-report

Gonadotropin Releasing Hormone Gnrh Agonist Market Report 2026

https://www.thebusinessresearchcompany.com/report/gonadotropin-releasing-hormone-gnrh-agonist-global-market-report

Male Hypogonadism Market Report 2026

https://www.thebusinessresearchcompany.com/report/male-hypogonadism-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795